SmartCriseS - Smartphone Survey of Suicidal Risk

Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Oct 24, 2018

Keywords

ClinConnect Summary

The SmartCriseS trial is studying the connection between sleep problems, appetite changes, and feelings of social isolation with suicidal thoughts and behaviors. Researchers believe that by using smartphone apps, they can gather real-time information about these factors from people who have recently experienced a suicidal crisis. The study aims to include 1,044 participants who have attempted suicide, and they will be followed for six months to see how these factors influence their feelings about life and death.

To be eligible for this trial, participants must be at least 18 years old, use a smartphone, and have sought help for a suicidal crisis within the last week. If you join, you can expect to answer questions through the smartphone apps and wear a device that tracks your sleep for the first 30 days. This research hopes to find important insights that could help improve support for individuals facing similar challenges. Remember, participation is voluntary, and it's crucial to understand the study's purpose before agreeing to take part.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • To be at least 18 years old
• • To use a smartphone as a personal phone
• • To have consulted in the context of a suicidal crisis within the last 7 days
• • To be able to understand the nature, purpose and methodoly of the study.
• • To be in a minimal treatment phase (according to the clinician's judgment).
• • To accept participating to the study and the 6 months follow-up and to have signed the informed consent
• Exclusion Criteria:
• • Refusal of participation
• • Subject protected by law (guardianship)
• • Deprived of liberty Subject (by judicial or administrative decision)
• • Diagnosis of a current hypomanic, manic or mixed episode, or a diagnosis of schizoaffective disorder or schizophrenia.
• • No affiliation to the social safety system
• • Exclusion period in relation to another protocol
• • 65 years old patients and older with an MMSE score \< 24 at baseline